BAV

Bio-Angle Vacs is a Malaysian animal-health biotechnology company focused on the development, manufacture, and commercialization of veterinary vaccines, pharmaceuticals, and health supplements for livestock and aquaculture. The company is best known for STVac, an intranasal bacterial vaccine for goats and sheep intended to protect against mannheimiosis/pneumonic pasteurellosis, which it describes as a first-in-world product created with researchers at Universiti Putra Malaysia. Bio-Angle Vacs also operates a cGMP-compliant bacterial animal vaccine manufacturing facility in Southeast Asia and offers contract manufacturing, quality-control, and validation services. Its business model combines proprietary veterinary products with manufacturing and compliance services, with a geographic emphasis on Malaysia and broader international animal-health markets.